May Wang
Corporate Officer/Principal at HUTCHMED (CHINA) LIMITED
Profile
Qing Mei Wang is currently working as the SVP-Business Development & Strategic Alliances at HUTCHMED (China) Ltd.
since 2010 and at Hutchison MediPharma Ltd.
since 2012.
Previously, Dr. Wang worked as the Head-Asia Discovery Biology at Eli Lilly & Co. Dr. Wang holds a doctorate degree from Purdue University.
May Wang active positions
| Companies | Position | Start |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Corporate Officer/Principal | 2009-12-31 |
Hutchison MediPharma Ltd.
 Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 2011-07-26 |
Former positions of May Wang
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Training of May Wang
| Purdue University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| HUTCHMED (CHINA) LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- May Wang
